Furthermore, fatty acids are synthesized actively in the liver because insulin resistance-associated hyperinsulinemia favors de novo lipogenesis (DNL; i.e., the synthesis of fatty acids from carbohydrates) via the activation of sterol regulatory element-binding protein 1c (SREBP1c). The gene discussed is SREBF1; the disease is Hyperinsulinemia.